Quintiles has been named a preferred provider to 14 global health Product Development Partnerships (PDPs), a consortium that leverages their combined pipelines in an effort the get the most cost effective use of their R&D spend. PDPs are not-for-profit entities seeking to discover, develop and deliver new affordable medicines for some of the most neglected diseases in the world. The 14 PDPs anticipate funding 128 Phase I-IV trials over the next two years. Quintiles will partner with the c...